DEF 14A: American Healthcare REIT Announces 2024 Annual Meeting and Executive Compensation Details

American Healthcare REIT's proxy statement details the agenda for the 2024 annual meeting, director nominees, and executive compensation, including a new employee stock purchase plan.

Summary

• American Healthcare REIT has announced its 2024 Annual Meeting of Stockholders to be held on November 7, 2024, in Irvine, California.
• The meeting will include voting on the election of nine directors, ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm, an advisory vote on executive compensation, and approval of the 2024 Employee Stock Purchase Plan.
• The proxy statement provides details on the director nominees, executive compensation, corporate governance, and related party transactions.
• The company's Board of Directors recommends voting FOR all director nominees, FOR the ratification of Deloitte & Touche, FOR the advisory vote on executive compensation, and FOR the approval of the Employee Stock Purchase Plan.
• As of August 23, 2024, there were 132,863,586 shares of common stock outstanding and entitled to vote.
• The company's portfolio consists of approximately $4.5 billion in healthcare real estate assets as of December 31, 2023.
• In 2023, total revenue increased by 13.6% to $1.87 billion, and same-store net operating income (NOI) increased by 8.6% across the portfolio.
• The company completed a public offering of 64.4 million shares of common stock in February 2024 and used the proceeds to pay down approximately $721 million of outstanding debt.
• The company has implemented corporate governance updates to align with NYSE listing requirements, including minimum stock ownership requirements for directors and officers and a clawback policy.

Sentiment

Score: 7

Explanation: The document presents a balanced view with positive financial performance metrics and corporate governance updates, but also acknowledges a net loss and potential risks.

Positives

• The company experienced a 13.6% increase in total revenue, reaching $1.87 billion in 2023.
• Same-store net operating income (NOI) increased by 8.6% across the portfolio in 2023, indicating improved operational efficiency.
• The successful public offering of 64.4 million shares of common stock in February 2024 strengthened the company's financial position.
• The company reduced its debt by approximately $721 million, lowering its financial risk.
• The implementation of corporate governance updates aligns the company with NYSE standards and enhances transparency and accountability.
• The company is committed to environmental, social, and governance (ESG) practices, aiming to reduce environmental impact and promote sustainability.

Negatives

• The company reported a net loss of $76.887 million for the year ended December 31, 2023.
• The company has a clawback policy that requires the repayment of incentive compensation paid or awarded to officers in certain cases if there is a financial restatement.

Risks

• The company's performance is subject to interest rate volatility impacting the real estate markets.
• The company's success depends on attracting and retaining skilled personnel to provide services at healthcare-related facilities.
• The company faces risks related to cybersecurity and internal controls, requiring ongoing monitoring and mitigation efforts.
• The company's performance is subject to the risks associated with the healthcare real estate industry.

Future Outlook

The company is focused on maximizing the value of its real estate portfolio, improving operational efficiency, and enhancing its corporate governance practices to align with NYSE listing requirements.

Management Comments

• Jeffrey T. Hanson, Non-Executive Chairman of the Board of Directors, urges stockholders to submit their proxy as soon as possible.
• Management will provide an update on the company's portfolio and performance at the 2024 Annual Meeting of Stockholders.

Industry Context

The announcement reflects the company's transition to a publicly listed REIT, with a focus on corporate governance, executive compensation, and financial performance metrics that are common in the REIT industry.

Comparison to Industry Standards

• The company's executive compensation peer group includes Brandywine Realty Trust, Highwoods Properties, Inc., Piedmont Office Realty Trust, Inc., CareTrust REIT, Inc., LTC Properties, Inc., Retail Opportunity Investments Corp., Global Medical REIT Inc., National Health Investors, Inc., Sabra Health Care REIT, Inc., Peakstone Realty Trust, Orion Office REIT, Inc., Sila Realty Trust, Inc., Healthcare Realty Trust Incorporated, Physicians Realty Trust, and SmartStop Self Storage REIT, Inc.
• The company's corporate governance guidelines are based on NYSE standards, which are common for publicly listed companies.
• The company's use of non-GAAP financial measures such as Adjusted EBITDA and Same-Store NOI is consistent with industry practices for REITs.

Corporate Governance

Related Party Transactions

• The company has entered into indemnification agreements with each of its directors and executive officers.
• Upon the closing of the 2024 Offering on February 9, 2024, we granted 972,222 Listing Equity Awards to our directors, executive officers and employees under our incentive plan in connection with the recent listing of our common stock on the NYSE.
• On January 24, 2024, we entered into lock-up agreements with each of our directors and executive officers, pursuant to which each such individual agreed not to transfer shares of our of our common stock held or subsequently acquired by such individual for the applicable lock-up period.

Stakeholder Impact

• The company's performance and governance practices impact shareholders, employees, customers, and the communities in which it operates.
• The company's commitment to ESG practices aims to create long-term value for stakeholders while contributing to a more sustainable future.

Next Steps

• Stockholders are urged to submit their proxy votes before the deadlines.
• The company will hold its 2024 Annual Meeting of Stockholders on November 7, 2024.
• The company will continue to implement its ESG policy and monitor its progress.
• The company will continue to evaluate and refine its corporate governance practices.

Key Dates

Keywords

executive compensation, annual meeting, corporate governance, healthcare REIT, stock purchase plan, director nominees, financial performance, real estate, Deloitte & Touche, proxy statement